| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenues | $5.1M+271.4% | $1.4M+124.7% | $607K |
| Cost of goods sold | -$3.6M-261.3% | -$990K-36.6% | -$725K |
| Gross profit (loss) | $1.5M+298.1% | $374K+416.9% | -$118K |
| General and administrative | $2.4M+96.5% | $1.2M-47.5% | $2.4M |
| Research and development | $1.9M+48.7% | $1.3M-37.1% | $2.0M |
| Sales and marketing | $2.9M+59.0% | $1.8M-28.7% | $2.5M |
| Non-cash expenses | $2.4M+8.3% | $2.2M+34.1% | $1.7M |
| Total operating expenses | $9.6M+46.8% | $6.6M-23.6% | $8.6M |
| Loss from operations | -$8.1M-31.6% | -$6.2M+28.9% | -$8.7M |
| Interest income | $203K+130.7% | $88K+60.0% | $55K |
| State & sales taxes | -$4K+33.3% | -$6K | $0 |
| Preferred dividends | -$513K | $0 | — |
| SEC settlements | $0+100.0% | -$426K-204.3% | -$140K |
| Realized gain/loss | -$2K | $0 | — |
| Net loss | -$8.5M-29.5% | -$6.5M+27.4% | -$9.0M |
| Deemed dividend for original issue discount on preferred shares | -$2.0M | $0 | — |
| Net Loss Available to Common Stockholders | -$10.4M-59.5% | -$6.5M | — |
| Basic | $18.83B+29.3% | $14.57B+2427749766.7% | -$600 |
| Diluted | $18.83B+29.3% | $14.57B+2427749766.7% | -$600 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.